JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403864200 on May 19, 2004

J. Biol. Chem., Vol. 279, Issue 29, 30252-30258, July 16, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/29/30252    most recent
M403864200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billecke, S. S.
Right arrow Articles by Osawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billecke, S. S.
Right arrow Articles by Osawa, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Role of hsp90 in Heme-dependent Activation of Apo-neuronal Nitric-oxide Synthase*

Scott S. Billecke, Dragomir I. Draganov, Yoshihiro Morishima, Patrick J. M. Murphy, Anwar Y. Dunbar, William B. Pratt, and Yoichi Osawa{ddagger}

From the Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan 48109-0632

Like other nitric-oxide synthase (NOS) enzymes, neuronal NOS (nNOS) turnover and activity are regulated by the ubiquitous protein chaperone hsp90. We have shown previously that nNOS expressed in Sf9 cells where endogenous heme levels are low is activated from the apo- to the holo-enzyme by addition of exogenous heme to the culture medium, and this activation is inhibited by radicicol, a specific inhibitor of hsp90 (Billecke, S. S., Bender, A. T., Kanelakis, K. C., Murphy, P. J. M., Lowe, E. R., Kamada, Y., Pratt, W. B., and Osawa, Y. (2002) J. Biol. Chem. 278, 15465–15468). In this work, we examine heme binding by apo-nNOS to form the active enzyme in a cell-free system. We show that cytosol from Sf9 cells facilitates heme-dependent apo-nNOS activation by promoting functional heme insertion into the enzyme. Sf9 cytosol also converts the glucocorticoid receptor (GR) to a state where the hydrophobic ligand binding cleft is open to access by steroid. Both cell-free heme activation of purified nNOS and activation of steroid binding activity of the immunopurified GR are inhibited by radicicol treatment of Sf9 cells prior to cytosol preparation, and addition of purified hsp90 to cytosol partially overcomes this inhibition. Although there is an hsp90-dependent machinery in Sf9 cytosol that facilitates heme binding by apo-nNOS, it is clearly different from the machinery that facilitates steroid binding by the GR. hsp90 regulation of apo-nNOS heme activation is very dynamic and requires higher concentrations of radicicol for its inhibition, whereas GR steroid binding is determined by assembly of stable GR·hsp90 heterocomplexes that are formed by a purified five-chaperone machinery that does not activate apo-nNOS.


Received for publication, April 7, 2004 , and in revised form, May 14, 2004.

* This work was supported by National Institutes of Health Grants ES08365 (to Y. O.) and DK31573 (to W. B. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Established Investigator of the American Heart Association. To whom correspondence should be addressed: Dept. of Pharmacology, The University of Michigan Medical School, 1301 Medical Science Research Bldg. III, Ann Arbor, MI 48109-0632. Tel.: 734-936-5797; Fax: 734-763-4450; E-mail: osawa{at}umich.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. B. Pratt, Y. Morishima, and Y. Osawa
The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts
J. Biol. Chem., August 22, 2008; 283(34): 22885 - 22889.
[Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Y. Dunbar, G. J. Jenkins, S. Jianmongkol, M. Nakatsuka, E. R. Lowe, M. Lau, and Y. Osawa
Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo
Drug Metab. Dispos., September 1, 2006; 34(9): 1448 - 1456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Yetik-Anacak, T. Xia, C. Dimitropoulou, R. C. Venema, and J. D. Catravas
Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxation
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H260 - H268.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. M. Murphy, Y. Morishima, J. J. Kovacs, T.-P. Yao, and W. B. Pratt
Regulation of the Dynamics of hsp90 Action on the Glucocorticoid Receptor by Acetylation/Deacetylation of the Chaperone
J. Biol. Chem., October 7, 2005; 280(40): 33792 - 33799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-M. Peng, Y. Morishima, G. J. Jenkins, A. Y. Dunbar, M. Lau, C. Patterson, W. B. Pratt, and Y. Osawa
Ubiquitylation of Neuronal Nitric-oxide Synthase by CHIP, a Chaperone-dependent E3 Ligase
J. Biol. Chem., December 17, 2004; 279(51): 52970 - 52977.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.